A Multicenter, Non-interventional Prospective Active Surveillance Study Among Participants Receiving Somatrogon Under Routine Clinical Care in India
Latest Information Update: 20 Oct 2024
At a glance
- Drugs Somatrogon (Primary)
- Indications Somatotropin deficiency
- Focus Adverse reactions
- Sponsors Pfizer
- 20 Oct 2024 New trial record